Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹75.3 Cr 1.5% -9.9% -59.4% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,501.2 Cr 0.5% -5.7% -13.1% Stock Analytics
KIRI INDUSTRIES ₹3,532.6 Cr 2.6% 1.4% -10.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,671.4 Cr 1.3% -8.1% -40% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,247.6 Cr 6% -6.2% 20.9% Stock Analytics
BODAL CHEMICALS ₹674.2 Cr 5.5% -0.9% -22% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1.5%

-9.9%

-59.4%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses